{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T08:28:43Z","timestamp":1794212923209,"version":"4.8.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-025-01956-3","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T06:13:35Z","timestamp":1755843215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Landscape analysis of m5C modification regulators unveils DNMT1-mediated dysregulated pyrimidine metabolism in hepatocellular carcinoma"],"prefix":"10.1186","volume":"17","author":[{"given":"Xuhui","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifu","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinling","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiren","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"1956_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"1956_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7: 6.","journal-title":"Nat Rev Dis Primers"},{"key":"1956_CR3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400:1345\u201362.","journal-title":"Lancet"},{"key":"1956_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2016.132","volume":"18","author":"BS Zhao","year":"2017","unstructured":"Zhao BS, Roundtree IA, He C. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2017;18:31\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1956_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.tem.2023.12.007","volume":"35","author":"KA Berggren","year":"2024","unstructured":"Berggren KA, Schwartz RE, Kleiner RE, Ploss A. The impact of epitranscriptomic modifications on liver disease. Trends Endocrinol Metab. 2024;35:331\u201346.","journal-title":"Trends Endocrinol Metab"},{"key":"1956_CR6","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1126\/science.1261417","volume":"347","author":"S Geula","year":"2015","unstructured":"Geula S, Moshitch-Moshkovitz S, Dominissini D, Mansour AA, Kol N, Salmon-Divon M, et al. Stem cells. m6A mRNA methylation facilitates resolution of na\u00efve pluripotency toward differentiation. Science. 2015;347:1002\u20136.","journal-title":"Science"},{"key":"1956_CR7","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","volume":"169","author":"IA Roundtree","year":"2017","unstructured":"Roundtree IA, Evans ME, Pan T, He C. Dynamic RNA modifications in gene expression regulation. Cell. 2017;169:1187\u2013200.","journal-title":"Cell"},{"key":"1956_CR8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.cell.2013.10.026","volume":"155","author":"J-M Fustin","year":"2013","unstructured":"Fustin J-M, Doi M, Yamaguchi Y, Hida H, Nishimura S, Yoshida M, et al. RNA-methylation-dependent RNA processing controls the speed of the circadian clock. Cell. 2013;155:793\u2013806.","journal-title":"Cell"},{"key":"1956_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1080\/15476286.2016.1267096","volume":"14","author":"S Nachtergaele","year":"2017","unstructured":"Nachtergaele S, He C. The emerging biology of RNA post-transcriptional modifications. RNA Biol. 2017;14:156\u201363.","journal-title":"RNA Biol"},{"key":"1956_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/gb4143","volume":"14","author":"S Hussain","year":"2013","unstructured":"Hussain S, Aleksic J, Blanco S, Dietmann S, Frye M. Characterizing 5-methylcytosine in the mammalian epitranscriptome. Genome Biol. 2013;14:215.","journal-title":"Genome Biol"},{"key":"1956_CR11","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1093\/nar\/gkp1117","volume":"38","author":"Y Motorin","year":"2010","unstructured":"Motorin Y, Lyko F, Helm M. 5-Methylcytosine in RNA: detection, enzymatic formation and biological functions. Nucleic Acids Res. 2010;38:1415\u201330.","journal-title":"Nucleic Acids Res"},{"key":"1956_CR12","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/cr.2017.55","volume":"27","author":"X Yang","year":"2017","unstructured":"Yang X, Yang Y, Sun B-F, Chen Y-S, Xu J-W, Lai W-Y, et al. 5-methylcytosine promotes mRNA export\u2014NSUN2 as the methyltransferase and ALYREF as an m5C reader. Cell Res. 2017;27:606\u201325.","journal-title":"Cell Res"},{"key":"1956_CR13","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41556-019-0361-y","volume":"21","author":"X Chen","year":"2019","unstructured":"Chen X, Li A, Sun B-F, Yang Y, Han Y-N, Yuan X, et al. 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. Nat Cell Biol. 2019;21:978\u201390.","journal-title":"Nat Cell Biol"},{"key":"1956_CR14","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.014226","volume":"296","author":"H Shen","year":"2021","unstructured":"Shen H, Ontiveros RJ, Owens MC, Liu MY, Ghanty U, Kohli RM, et al. TET-mediated 5-methylcytosine oxidation in tRNA promotes translation. J Biol Chem. 2021;296: 100087.","journal-title":"J Biol Chem"},{"key":"1956_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31876-2","volume":"13","author":"AE Arguello","year":"2022","unstructured":"Arguello AE, Li A, Sun X, Eggert TW, Mairhofer E, Kleiner RE. Reactivity-dependent profiling of RNA 5-methylcytidine dioxygenases. Nat Commun. 2022;13: 4176.","journal-title":"Nat Commun"},{"key":"1956_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1639","volume":"12","author":"Y-S Chen","year":"2021","unstructured":"Chen Y-S, Yang W-L, Zhao Y-L, Yang Y-G. Dynamic transcriptomic m5C and its regulatory role in RNA processing. WIREs RNA. 2021;12: e1639.","journal-title":"WIREs RNA"},{"key":"1956_CR17","first-page":"2989","volume":"12","author":"T Zhang","year":"2022","unstructured":"Zhang T, Gu J, Wang X, Luo J, Yan J, Cai K, et al. RNA methylation regulators contribute to poor prognosis of hepatocellular carcinoma associated with the suppression of bile acid metabolism: a multi-omics analysis. Am J Cancer Res. 2022;12:2989\u20133013.","journal-title":"Am J Cancer Res"},{"key":"1956_CR18","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1016\/j.cell.2023.09.011","volume":"186","author":"D Mossmann","year":"2023","unstructured":"Mossmann D, M\u00fcller C, Park S, Ryback B, Colombi M, Ritter N, et al. Arginine reprograms metabolism in liver cancer via RBM39. Cell. 2023;186:5068-5083.e23.","journal-title":"Cell"},{"key":"1956_CR19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","volume":"12","author":"D Du","year":"2022","unstructured":"Du D, Liu C, Qin M, Zhang X, Xi T, Yuan S, et al. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm Sin B. 2022;12:558\u201380.","journal-title":"Acta Pharm Sin B"},{"key":"1956_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41419-022-04596-0","volume":"13","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Cao C, Zhang D, Zhang Z, Liu L, Wu D, et al. UBE2T-mediated akt ubiquitination and akt\/\u03b2-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism. Cell Death Dis. 2022;13:154.","journal-title":"Cell Death Dis"},{"key":"1956_CR21","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","volume":"24","author":"M De Martino","year":"2024","unstructured":"De Martino M, Rathmell JC, Galluzzi L, Vanpouille-Box C. Cancer cell metabolism and antitumour immunity. Nat Rev Immunol. 2024;24:654\u201369.","journal-title":"Nat Rev Immunol"},{"key":"1956_CR22","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","volume":"13","author":"L Sun","year":"2022","unstructured":"Sun L, Zhang H, Gao P. Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein Cell. 2022;13:877\u2013919.","journal-title":"Protein Cell"},{"key":"1956_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/1878-0261.12153","volume":"12","author":"OV Grinchuk","year":"2018","unstructured":"Grinchuk OV, Yenamandra SP, Iyer R, Singh M, Lee HK, Lim KH, et al. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma. Mol Oncol. 2018;12:89\u2013113.","journal-title":"Mol Oncol"},{"key":"1956_CR24","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1136\/gutjnl-2014-308483","volume":"65","author":"E Villa","year":"2016","unstructured":"Villa E, Critelli R, Lei B, Marzocchi G, Camm\u00e0 C, Giannelli G, et al. Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study. Gut. 2016;65:861\u20139.","journal-title":"Gut"},{"key":"1956_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.869993","volume":"13","author":"Q He","year":"2022","unstructured":"He Q, Yang J, Jin Y. Development and validation of TACE refractoriness-related diagnostic and prognostic scores and characterization of tumor microenvironment infiltration in hepatocellular carcinoma. Front Immunol. 2022;13: 869993.","journal-title":"Front Immunol"},{"key":"1956_CR26","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1038\/s41467-022-32283-3","volume":"13","author":"Y Lu","year":"2022","unstructured":"Lu Y, Yang A, Quan C, Pan Y, Zhang H, Li Y, et al. A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma. Nat Commun. 2022;13:4594.","journal-title":"Nat Commun"},{"key":"1956_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41392-020-0205-z","volume":"5","author":"RD Cervantes-Villagrana","year":"2020","unstructured":"Cervantes-Villagrana RD, Albores-Garc\u00eda D, Cervantes-Villagrana AR, Garc\u00eda-Acevez SJ. Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. Signal Transduct Target Ther. 2020;5:99.","journal-title":"Signal Transduct Target Ther"},{"key":"1956_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217059","volume":"597","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, Zhou Y, Lv P, Zhou T, Liu H, Xie Y, et al. NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilization. Cancer Lett. 2024;597: 217059.","journal-title":"Cancer Lett"},{"key":"1956_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12943-024-02041-8","volume":"23","author":"Y Li","year":"2024","unstructured":"Li Y, Jin H, Li Q, Shi L, Mao Y, Zhao L. The role of RNA methylation in tumor immunity and its potential in immunotherapy. Mol Cancer. 2024;23:130.","journal-title":"Mol Cancer"},{"key":"1956_CR30","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41392-022-01175-9","volume":"7","author":"L Cui","year":"2022","unstructured":"Cui L, Ma R, Cai J, Guo C, Chen Z, Yao L, et al. RNA modifications: importance in immune cell biology and related diseases. Signal Transduct Target Ther. 2022;7:334.","journal-title":"Signal Transduct Target Ther"},{"key":"1956_CR31","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","volume":"39","author":"J Feng","year":"2020","unstructured":"Feng J, Li J, Wu L, Yu Q, Ji J, Wu J, et al. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2020;39:126.","journal-title":"J Exp Clin Cancer Res"},{"key":"1956_CR32","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.cmet.2023.07.009","volume":"35","author":"T Chen","year":"2023","unstructured":"Chen T, Xu Z-G, Luo J, Manne RK, Wang Z, Hsu C-C, et al. NSUN2 is a glucose sensor suppressing cGAS\/STING to maintain tumorigenesis and immunotherapy resistance. Cell Metab. 2023;35:1782-1798.e8.","journal-title":"Cell Metab"},{"key":"1956_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.918140","volume":"13","author":"D Li","year":"2022","unstructured":"Li D, Li K, Zhang W, Yang K-W, Mu D-A, Jiang G-J, et al. The m6A\/m5C\/m1A regulated gene signature predicts the prognosis and correlates with the immune status of hepatocellular carcinoma. Front Immunol. 2022;13: 918140.","journal-title":"Front Immunol"},{"key":"1956_CR34","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1039\/D3AN01915B","volume":"149","author":"Y Yu","year":"2024","unstructured":"Yu Y, Fu W, Xie Y, Jiang X, Wang H, Yang X. A review on recent advances in assays for DNMT1: a promising diagnostic biomarker for multiple human cancers. Analyst. 2024;149:1002\u201321.","journal-title":"Analyst"},{"key":"1956_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41392-022-00896-1","volume":"7","author":"Y Fu","year":"2022","unstructured":"Fu Y, Zhang X, Liu X, Wang P, Chu W, Zhao W, et al. The DNMT1-PAS1-PH20 axis drives breast cancer growth and metastasis. Signal Transduct Target Ther. 2022;7:81.","journal-title":"Signal Transduct Target Ther"},{"key":"1956_CR36","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41418-019-0389-3","volume":"27","author":"H Liu","year":"2020","unstructured":"Liu H, Song Y, Qiu H, Liu Y, Luo K, Yi Y, et al. Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis. Cell Death Differ. 2020;27:966\u201383.","journal-title":"Cell Death Differ"},{"key":"1956_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304329","volume":"10","author":"K Wang","year":"2023","unstructured":"Wang K, Li F-H, Zhou L-Y, Zhao X-M, Gao X-Q, Liu C-Y, et al. HNEAP regulates necroptosis of cardiomyocytes by suppressing the m5 C methylation of Atf7 mRNA. Adv Sci (Weinh). 2023;10: e2304329.","journal-title":"Adv Sci (Weinh)"},{"key":"1956_CR38","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nrd4504","volume":"14","author":"U Asghar","year":"2015","unstructured":"Asghar U, Witkiewicz AK, Turner NC, Knudsen ES. The history and future of targeting cyclin-dependent kinases in cancer therapy. Nat Rev Drug Discov. 2015;14:130\u201346.","journal-title":"Nat Rev Drug Discov"},{"key":"1956_CR39","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.canlet.2018.11.019","volume":"443","author":"B Xie","year":"2019","unstructured":"Xie B, Wang S, Jiang N, Li JJ. Cyclin B1\/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance. Cancer Lett. 2019;443:56\u201366.","journal-title":"Cancer Lett"},{"key":"1956_CR40","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.63835","volume":"9","author":"JR Ow","year":"2020","unstructured":"Ow JR, Caldez MJ, Zafer G, Foo JC, Li HY, Ghosh S, et al. Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division. Elife. 2020;9: e63835.","journal-title":"Elife"},{"key":"1956_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202205873","volume":"10","author":"T Guan","year":"2023","unstructured":"Guan T, Li M, Song Y, Chen J, Tang J, Zhang C, et al. Phosphorylation of USP29 by CDK1 governs TWIST1 stability and oncogenic functions. Adv Sci (Weinh). 2023;10: e2205873.","journal-title":"Adv Sci (Weinh)"},{"key":"1956_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s10020-021-00302-6","volume":"27","author":"Q Shi","year":"2021","unstructured":"Shi Q, Ni X, Lei M, Xia Q, Dong Y, Zhang Q, et al. Phosphorylation of islet-1 serine 269 by CDK1 increases its transcriptional activity and promotes cell proliferation in gastric cancer. Mol Med. 2021;27:47.","journal-title":"Mol Med"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01956-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-025-01956-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01956-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:05:13Z","timestamp":1757415913000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-025-01956-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1956"],"URL":"https:\/\/doi.org\/10.1186\/s13148-025-01956-3","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"7 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The collection of specimens of clinical patients in this study was approved by the Research Ethics Committee of Zhongshan Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"144"}}